Related Experiment Video
Updated: Aug 11, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
High prevalence of CBS p.T191M mutation in homocystinuric patients from Colombia
Marta Bermúdez1, Nina Frank, Jaime Bernal
1Instituto de Genética Humana Pontificia Universidad Javeriana, Bogotá, Colombia.
Insights
This study analyzed homocystinuria in Colombian patients, identifying the common p.T191M mutation and a new p.A288T mutation. Many carriers showed elevated homocysteine, increasing vascular disease risk.
Area of Science:
- Genetics
- Biochemistry
- Clinical Medicine
Background:
- Homocystinuria is an autosomal recessive disorder often caused by cystathionine beta-synthase (CBS) gene mutations.
- Understanding genetic variations is crucial for diagnosing and managing metabolic disorders.
Purpose of the Study:
- To perform molecular characterization of homocystinuria in Colombian patients.
- To identify CBS gene mutations and analyze genotype-phenotype correlations.
Main Methods:
- Mutation analysis of the CBS gene in 36 individuals from 10 Colombian kindreds.
- Genotype-phenotype assessment of patients and heterozygous relatives.
Main Results:
- The prevalent p.T191M mutation was found in seven homozygous patients, exhibiting variable clinical severity.
- No biochemical response to pyridoxine and folic acid was observed.
- Heterozygous relatives often had elevated total homocysteine levels, indicating increased vascular disease risk.
- A novel mutation, p.A288T, was identified in one individual.
Conclusions:
- The p.T191M mutation is a significant cause of homocystinuria in Colombia.
- Elevated homocysteine levels in carriers highlight potential risks beyond classical homocystinuria.
- Molecular analysis provides critical insights into homocystinuria in diverse populations.
Abstract:
Homocystinuria is an autosomal recessive disease most commonly caused by mutations in cystathionine beta-synthase (CBS). In this study we present the mutation analysis of 36 Colombian individuals from 10 unrelated kindred, with 11 individuals clinically classified as homocystinuric. Mutation analysis of the CBS gene revealed p.T191M, a prevalent mutation in Spain and Portugal, in the homozygous state in seven of the unrelated patients. Genotype-phenotype assessment of the p.T191M homozygous patients showed a high level of variability, including different severity in one pair of affected siblings. None of the patients responded biochemically to treatment with pharmacological doses of pyridoxine and folic acid as revealed by essentially unchanged homocysteine levels. This study offered a unique opportunity to study 18 heterozygous (p.T191M/wt) relatives of the homocystinuric patients. One atypical finding was that many of them presented with above average total homocysteine levels, putting them at an increased risk for vascular disease. Cryptorchidism was present in three of the cases, one of which presented also with Klinefelter syndrome. In addition to the previously described p.T191M mutation, a new mutation, p.A288T, was identified in a single individual. In this paper we present the first characterization, at a molecular level, of patients with homocystinuria from Colombia.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

